Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition
NCT01577914
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Fasting State
Interventions
DRUG:
Carvedilol Tablets USP 12.5 mg
DRUG:
Carvedilol
Sponsor
IPCA Laboratories Ltd.